Laura A. Baker

Most-cited papers

1. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

   Yan Ni Loh, E. L. Hedditch, Laura A. Baker, E. Jary +2 more

   2013BMC Cancer118 citations Open access

   Semantic Scholar

   Save

2. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

   R. Nair, DL Roden, W. Teo, A. McFarland +22 more

   2014Oncogene101 citations

   Semantic Scholar

   Save

3. ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

   S. Junankar, Laura A. Baker, D. Roden, R. Nair +21 more

   2015Nature Communications63 citations Open access

   Semantic Scholar

   Save

4. Epigenomics of mammary gland development

   Holly Holliday, Laura A. Baker, S. Junankar, S. Clark +1 more

   2018Breast Cancer Research38 citations Open access

   Semantic Scholar

   Save

5. Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1

   W. Teo, Holly Holliday, N. Karthikeyan, Aurélie S. Cazet +23 more

   2020Frontiers in Cell and Developmental Biology33 citations Open access

   Semantic Scholar

   Save

6. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer.

   Laura A. Baker, Holly Holliday, A. Swarbrick

   2016Endocrine-Related Cancer26 citations

   Semantic Scholar

   Save

7. Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy

   Archana P. Thankamony, Reshma Murali, N. Karthikeyan, Binitha Anu Varghese +14 more

   2020Biomolecules16 citations Open access

   Semantic Scholar

   Save

8. Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEB

   Holly Holliday, D. Roden, S. Junankar, Sunny Z. Wu +13 more

   2021iScience14 citations Open access

   Semantic Scholar

   Save

9. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

   Laura A. Baker, Holly Holliday, D. Roden, C. Krisp +26 more

   2020Breast Cancer Research12 citations Open access

   Semantic Scholar

   Save

10. Single cell transcriptomics reveals molecular subtype and functional heterogeneity in models of breast cancer

    D. Roden, Laura A. Baker, Benjamin L. Elsworth, Chia-Ling Chan +6 more

    2018bioRxiv6 citations Open access

    Semantic Scholar

    Save

11. Id proteins promote a cancer stem cell phenotype in triple negative breast cancer via Robo1-dependent c-Myc activation

    W. Teo, Aurélie S. Cazet, D. Roden, K. Harvey +23 more

    2018bioRxiv4 citations Open access

    Semantic Scholar

    Save

12. Inhibitor of Differentiation 4 (ID4) represses myoepithelial differentiation of mammary stem cells through its interaction with HEB

    Holly Holliday, D. Roden, S. Junankar, Sunny Z. Wu +13 more

    2020bioRxiv0 citations Open access

    Semantic Scholar

    Save

13. Id proteins promote a cancer stem cell phenotype in triple negative 1 breast cancer via negative regulation of Robo 1 2

    W. Teo, Holly Holliday, N. Karthikeyan, Aurélie S. Cazet +23 more

    20200 citations

    Semantic Scholar

    Save

14. A novel role for the HLH protein Inhibitor of Differentiation 4 (ID4) in the DNA damage response in basal-like breast cancer

    Laura A. Baker, C. Krisp, D. Roden, Holly Holliday +25 more

    2018bioRxiv0 citations Open access

    Semantic Scholar

    Save

15. Abstract LB-62: Inhibitor of differentiation 4 (ID4) maintains mammary stem cell homeostasis and identifies a poor-prognosis subset of basal-like breast cancers with a putative stem cell of origin

    S. Junankar, Laura A. Baker, Kyuson Yun, A. Swarbrick

    20140 citations

    Semantic Scholar

    Save